RajniAgarwalMD

Pediatric Hematology & Oncology • Palo Alto, CA

Pediatric Hematologic Oncology

Pediatric Stem Cell Transplant and Regenerative Medicine

Join to view full profile

Dr. Agarwal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Agarwal's full profile

Already have an account?

Office
725 Welch Rd
Palo Alto, CA 94304
Phone+1 650-497-8000

Fax+1 650-497-8959

Education & Training

Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1994 - 1995
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 1992
M.G.M. Medical CollegeClass of 1983

Certifications & Licensure

CA State Medical License 2001 - 2025
OH State Medical License 1994 - 2001

Clinical Trials

Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection Start of enrollment: 2014 Mar 01
Completed
Phase 3
CD34+ Cell Enriched and T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Mismatched Related Donors or Borderline Organ Function Start of enrollment: 2014 May 01
Completed
Not Applicable
JSP191 Antibody Targeting Conditioning in SCID Patients Start of enrollment: 2017 Mar 20
Recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

2 citations
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II intervent...
Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, Paibel Aguayo-Hiraldo, Christopher C Dvorak
Nature Communications. 2024-04-18
1 citations
Effect of Testicular Boost in Children With Leukemia Receiving Total Body Irradiation and Stem Cell Transplant: A Single-Institution Experience.
Erik S Blomain, Alice Jiang, Sarah S Donaldson, Rajni Agarwal, Alice Bertaina
Advances in Radiation Oncology. 2022-09-13
3 citations
Brentuximab Vedotin as Consolidation Therapy After Autologous Stem Cell Transplantation in Children and Adolescents (<18 y) With Early Relapse Hodgkin Lymphoma.
Karen S. Fernandez, Melissa Mavers, Lianna J. Marks, Rajni Agarwal
Journal of Pediatric Hematology/oncology. 2021-03-01

Lectures

Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)Cl...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Administration of BPX-501 Following Αβ-T and B-Cell Depleted Haplo-HSCT in Children with Transfusion-Dependent Thalassemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting & ExpositionDecember 9th, 2019
Using Antibody in Treatment of ‘Bubble Boy Disease’ Shows Early PromiseFebruary 28th, 2018